Cargando…
Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews
INTRODUCTION: The introduction of targeted therapies for cancer has contributed to dramatic improvements in patient survival. Nevertheless, several targeted therapies have been associated with ‘off-target’ adverse effects, based on varying levels of evidence. To date, this evidence has not been syst...
Autores principales: | van Leeuwen, Marina T, Luu, Steven, Gurney, Howard, Brown, Martin R, Webber, Kate, Pearson, Sallie-Anne, Hunt, Lee, Vajdic, Claire M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042572/ https://www.ncbi.nlm.nih.gov/pubmed/29950466 http://dx.doi.org/10.1136/bmjopen-2017-021064 |
Ejemplares similares
-
Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews
por: Van Leeuwen, Marina T, et al.
Publicado: (2020) -
Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study
por: Daniels, Benjamin, et al.
Publicado: (2023) -
Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors
por: Hong, Soojung, et al.
Publicado: (2022) -
Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data
por: van Leeuwen, Marina T, et al.
Publicado: (2018) -
Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort
por: Daniels, Benjamin, et al.
Publicado: (2017)